Patents Assigned to LifeScience AS
  • Sialic acid compositions for the use of inhibiting and treating coronavirus infection
    Patent number: 12390481
    Abstract: The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
    Type: Grant
    Filed: November 13, 2023
    Date of Patent: August 19, 2025
    Assignee: LifeScience AS
    Inventor: Jan Remmereit
  • Sialic acid compositions for the use of inhibiting and treating coronavirus infection
    Patent number: 11813271
    Abstract: The present invention relates to the use of compositions comprising sialic acid to inhibit or treat coronavirus infections, and in particular those caused by SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2).
    Type: Grant
    Filed: March 31, 2021
    Date of Patent: November 14, 2023
    Assignee: LifeScience AS
    Inventor: Jan Remmereit